Hua Medicine (Shanghai) Ltd.
HKEX:2552.HK
1.15 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3.14 | 3.14 | 35.166 | 35.166 | 8.8 | 8.8 | 0 | 0 | -0.241 | -0.241 | 0.241 | 0.241 | 4.169 | 4.169 | 0.164 | 0.164 | 11.108 | 11.108 | 0.021 | 0.021 | 1.346 | 1.346 | 0.632 | 5.806 | 5.258 | 5.258 | 0 | 0 |
| Cost of Revenue
| 6.476 | 6.476 | 13.142 | 13.142 | 4.955 | 4.955 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -3.337 | -3.337 | 22.024 | 22.024 | 3.845 | 3.845 | 0 | 0 | -0.241 | -0.241 | 0.241 | 0.241 | 4.169 | 4.169 | 0.164 | 0.164 | 11.108 | 11.108 | 0.021 | 0.021 | 1.346 | 1.346 | 0.632 | 5.806 | 5.258 | 5.258 | 0 | 0 |
| Gross Profit Ratio
| -1.063 | -1.063 | 0.626 | 0.626 | 0.437 | 0.437 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Reseach & Development Expenses
| 50.27 | 50.27 | 35.499 | 35.499 | 28.621 | 28.621 | 36.143 | 36.143 | 44.427 | 44.427 | 48.991 | 48.991 | 54.355 | 54.355 | 56.127 | 56.127 | 77.701 | 77.701 | 83.252 | 83.252 | 86.688 | 86.688 | 52.348 | 43.342 | 45.211 | 45.211 | 24.454 | 10.461 |
| General & Administrative Expenses
| 35.066 | 35.066 | 27.009 | 27.009 | 30.698 | 30.698 | 34.268 | 34.268 | 35.659 | 35.659 | 31.759 | 31.759 | 37.918 | 37.918 | 32.124 | 32.124 | 36.171 | 36.171 | 37.121 | 37.121 | 34.015 | 34.015 | 42.953 | 24.24 | 10.06 | 10.06 | 6.666 | 4.3 |
| Selling & Marketing Expenses
| 13.417 | 13.417 | 26.461 | 26.461 | 7.674 | 7.674 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 48.483 | 48.483 | 53.469 | 53.469 | 38.372 | 38.372 | 34.268 | 34.268 | 35.659 | 35.659 | 31.759 | 31.759 | 37.918 | 37.918 | 32.124 | 32.124 | 36.171 | 36.171 | 37.121 | 37.121 | 34.015 | 34.015 | 42.953 | 24.24 | 10.06 | 10.06 | 6.666 | 4.3 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.632 | -5.806 | 0 | 0 | -38.271 | -138.704 |
| Operating Expenses
| 59.328 | 59.328 | 69.279 | 69.279 | 53.629 | 53.629 | 52.256 | 52.256 | 80.13 | 80.13 | 83.28 | 83.28 | 113.535 | 113.535 | 87.351 | 87.351 | 107.594 | 107.594 | 119.375 | 119.375 | 1,050.294 | 1,050.294 | 94.669 | 61.776 | 31.506 | 31.506 | 31.12 | 14.761 |
| Operating Income
| -102.089 | -102.089 | -66.945 | -66.945 | -63.148 | -63.148 | -70.411 | -70.411 | -80.326 | -80.326 | -80.51 | -80.51 | -88.104 | -88.104 | -88.087 | -88.087 | -102.764 | -102.764 | -120.352 | -120.352 | -119.357 | -119.357 | -1,184.851 | -317.96 | -50.014 | -50.014 | -72.654 | -154.104 |
| Operating Income Ratio
| -32.517 | -32.517 | -1.904 | -1.904 | -7.176 | -7.176 | 0 | 0 | 333.994 | 333.994 | -334.759 | -334.759 | -21.136 | -21.136 | -538.758 | -538.758 | -9.252 | -9.252 | -5,731.024 | -5,731.024 | -88.708 | -88.708 | -1,874.764 | -54.764 | -9.513 | -9.513 | 0 | 0 |
| Total Other Income Expenses Net
| 41.52 | 41.52 | 21.897 | 21.897 | 13.704 | 13.704 | 18.102 | 18.102 | 0.105 | 0.105 | -2.137 | -2.137 | -21.736 | -21.736 | 1.36 | 1.36 | 7.879 | 7.879 | 2.602 | 2.602 | -929.173 | -929.173 | 0.234 | -4.362 | 24.052 | 24.052 | -2.11 | 0.104 |
| Income Before Tax
| -60.569 | -60.569 | -45.048 | -45.048 | -49.444 | -49.444 | -52.31 | -52.31 | -80.221 | -80.221 | -82.646 | -82.646 | -109.84 | -109.84 | -86.728 | -86.728 | -94.885 | -94.885 | -117.75 | -117.75 | -1,048.53 | -1,048.53 | -1,184.617 | -322.322 | -25.962 | -25.962 | -74.764 | -154 |
| Income Before Tax Ratio
| -19.293 | -19.293 | -1.281 | -1.281 | -5.619 | -5.619 | 0 | 0 | 333.559 | 333.559 | -343.642 | -343.642 | -26.35 | -26.35 | -530.443 | -530.443 | -8.542 | -8.542 | -5,607.143 | -5,607.143 | -779.286 | -779.286 | -1,874.394 | -55.515 | -4.938 | -4.938 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.237 | 3.093 | -1.996 | -1.996 | -1.478 | -0.498 |
| Net Income
| -60.569 | -60.569 | -45.048 | -45.048 | -49.444 | -49.444 | -52.31 | -52.31 | -80.221 | -80.221 | -82.646 | -82.646 | -109.84 | -109.84 | -86.728 | -86.728 | -94.885 | -94.885 | -117.75 | -117.75 | -1,048.53 | -1,048.53 | -1,184.38 | -325.415 | -23.966 | -23.966 | -73.286 | -153.502 |
| Net Income Ratio
| -19.293 | -19.293 | -1.281 | -1.281 | -5.619 | -5.619 | 0 | 0 | 333.559 | 333.559 | -343.642 | -343.642 | -26.35 | -26.35 | -530.443 | -530.443 | -8.542 | -8.542 | -5,607.143 | -5,607.143 | -779.286 | -779.286 | -1,874.019 | -56.048 | -4.558 | -4.558 | 0 | 0 |
| EPS
| -0.062 | -0.062 | -0.046 | -0.046 | -0.051 | -0.051 | -0.055 | -0.055 | -0.084 | -0.084 | -0.087 | -0.087 | -0.12 | -0.12 | -0.091 | -0.091 | -0.1 | -0.1 | -0.13 | -0.13 | -1.73 | -1.73 | -1.13 | -0.31 | -0.23 | -0.23 | -0.07 | -0.15 |
| EPS Diluted
| -0.062 | -0.062 | -0.046 | -0.046 | -0.051 | -0.051 | -0.055 | -0.055 | -0.084 | -0.084 | -0.087 | -0.087 | -0.12 | -0.12 | -0.091 | -0.091 | -0.1 | -0.1 | -0.13 | -0.13 | -1.73 | -1.73 | -1.13 | -0.31 | -0.23 | -0.23 | -0.07 | -0.15 |
| EBITDA
| -98.121 | -98.121 | -62.997 | -62.997 | -60.057 | -60.057 | -67.352 | -67.352 | -77.398 | -77.398 | -77.446 | -77.446 | -86.768 | -86.768 | -86.949 | -86.949 | -101.878 | -101.878 | -119.557 | -119.557 | -118.844 | -118.844 | -1,184.584 | -317.719 | -49.817 | -49.817 | -72.524 | -153.991 |
| EBITDA Ratio
| -31.254 | -31.254 | -1.791 | -1.791 | -6.825 | -6.825 | 0 | 0 | 321.819 | 321.819 | -322.019 | -322.019 | -20.815 | -20.815 | -531.795 | -531.795 | -9.172 | -9.172 | -5,693.19 | -5,693.19 | -88.327 | -88.327 | -1,874.342 | -54.723 | -9.475 | -9.475 | 0 | 0 |